HIGHLIGHTS
- who: Ana Colon Ramos and collaborators from the Medicine, Tower Health Reading Hospital, West Reading, USA have published the Article: Open Access Review T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches, in the Journal: (JOURNAL) of February/09,/2021
- what: The alemtuzumab-resistant relapse form of T-PLL is inevitable, and an approach to increase the sensitivity to alemtuzumab is reasonable.
- how: In the same study similar results were obtained in_vivo in two patients with late-stage refractory disease when used as a single agent.
- future: Prospective study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.